england journal of medicine

Drug-resistant gonorrhea becoming serious problem

NYDailyNews.com - Health - NY Daily News  Mon, 02/13/2012 - 11:13

Researchers are issuing more dire warnings about the growing threat of multi-drug-resistant gonorrhea in the US, according to a new paper published the New England Journal of Medicine.


 

University of Maryland finds restricting post-surgery blood tran...

EurekAlert! - Medicine and Health  Tue, 12/13/2011 - 23:00

(University of Maryland Medical Center) More than half of the older, anemic patients in a New England Journal of Medicine study did not need blood transfusions as they recovered from hip surgery, according to new research co-authored by University of Maryland School of Medicine scientists.

The study found no significant difference in rate of recovery between patients who received transfusions at a moderate level of anemia and those who did not receive transfusions until their anemia was more advanced.


 

Clinical trial shows first evidence that anal cancer is preventa...

EurekAlert! - Cancer  Tue, 10/25/2011 - 22:00

(University of California - San Francisco) A large, international clinical trial led by doctors at the University of California, San Francisco indicates that a vaccine to prevent anal cancer is safe and effective, according to a study reported in the Oct. 27, 2011 issue of New England Journal of Medicine.


 

Federal investment in electronic health records likely to reap r...

EurekAlert! - Medicine and Health  Tue, 08/30/2011 - 22:00

(Case Western Reserve University) Research published in the New England Journal of Medicine gives cause for optimism that federal investments in electronic health records (EHRs) could reap major benefits in better patient care and health outcomes.A study based in the Cleveland (Ohio) area involving more than 27,000 adults with diabetes found that those in physician practices using EHRs were significantly more likely to have health care and outcomes that align with accepted standards than those where doctors rely on paper records.


 

Pacific Biosciences DNA sequencing technology yields new insight...

EurekAlert! - Infectious and Emerging Diseases  Tue, 07/26/2011 - 22:00

(Bioscribe) An international team of scientists has successfully employed single molecule, real-time (SMRT) DNA sequencing technology from Pacific Biosciences of California Inc. to provide valuable insights into the pathogenicity and evolutionary origins of the highly virulent bacterium responsible for the German E. coli outbreak.

Published online today in the New England Journal of Medicine, the results provide the most detailed genetic profile to date of the outbreak strain, including medically relevant information.


 

Study Examines the Placebo Response in Patients With Asthma

NCCAM Featured Content  Fri, 07/15/2011 - 13:25

A recent study sheds light on the placebo's effect on subjective and objective outcome measures in clinical trials.

The study, published in The New England Journal of Medicine, was conducted by researchers at Harvard Medical School in Boston; Endicott College in Beverly, Massachusetts; and the University of Hull in the United Kingdom.


 

Serendipity leads to lifesaving discovery

EurekAlert! - Infectious and Emerging Diseases  Tue, 05/10/2011 - 22:00

(McGill University) McGill research team recently published new findings in the New England Journal of Medicine, pointing to a critical role for IRF8 in the development and function of monocytes and dendritic cells and in protecting against mycobacterial infections like TB in humans.


 

Surgery reduces risk of mortality due to prostate cancer even fo...

EurekAlert! - Cancer  Wed, 05/04/2011 - 22:00

(Uppsala University) A Swedish research team partly consisting of researchers from Uppsala University followed a group of prostate cancer patients in the Nordic region for 15 years.

The study found, among other things, that surgery reduces the risk that men with prostate cancer (even those with low-risk tumors) will die within 15 years.

The results were published today in the New England Journal of Medicine.


 

Placing value, price on new drugs: The challenge facing new UK p...

EurekAlert! - Medicine and Health  Thu, 03/31/2011 - 22:00

(Johns Hopkins Medical Institutions) The United States should pay close attention to how the United Kingdom carries out plans to assess a new drug's worth using factors that go beyond clinical and cost effectiveness, according to researchers at the Johns Hopkins Berman Institute of Bioethics.

In a commentary to appear in the April 7 issue of the New England Journal of Medicine, the bioethicists detail and discuss a new, "value-based pricing" policy proposed by the British government.